School-based clusters of meningococcal disease in the United States: Descriptive epidemiology and a case-control analysis

JAMA

Volumn 277, Issue 5, 1997, Pages 389-395

  Zangwill, Kenneth M ^a,b   Schuchat, Anne ^a   Riedo, Francis X ^a,c   Pinner, Robert W ^a,d   Koo, Denise T ^a,e   Reeves, Michael W ^a   Wenger, Jay D ^a,f  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e CDC

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ARTICLE; CASE CONTROL STUDY; CHILD; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0031047060     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.5.389     Document Type: Article

References (26)

1. Hume SE. Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria. JAMA. 1992;267:1834, 1837-1838.
2. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA. 1995; 273:383-389.
3. Feigin RD, Baker CJ, Herwaldt LA, Lampe RM, Mason EO, Whitney SE. Epidemic meningococcal disease in an elementary school classroom. N Engl J Med. 1982;307:1255-1257.
4. Morrow HW, Slaten DD, Reingold AL, Werner SB, Fenstersheib MD. Meningococcal disease: risk factors associated with a school-related outbreak of serogroup C meningococcal disease. Pediatr Infect Dis J. 1990;9:394-398.
5. Hudson PJ, Vogt RL, Heun EM, et al. Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr Infect Dis J. 1986;5:213-217.
6. Harrison LH, Armstrong CW, Jenkins SR, et al. A cluster of meningococcal disease on a school bus following epidemic influenza. Arch Intern Med. 1991; 151:1005-1009.
7. Jacobson JA, Camargos PAM, Ferreira JT, McCormick JB. The risk of meningitis among classroom contacts during an epidemic of meningococcal disease. Am J Epidemiol. 1976;104:552-555.
8. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR Morb Mortal Wkly Rep. 1993;42(SS-2):21-30.
9. Selander RK, Caugant DA, Ochman H, Musser JN, Gilmour MN, Whittam TS. Methods of multi-locus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986;51:873-884.
10. SAS/STAT Software: Changes and Enhancements Through Release 6.11. Cary, NC: SAS Institute, Inc; 1996.
11. Centers for Disease Control and Prevention. Serogroup B meningococcal disease: Oregon, 1994. MMWR Morbid Mortal Wkly Rep. 1995;44:121-124.
12. The Meningococcal Disease Surveillance Group. Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA. 1976;235:261-265.
13. Munford RS, Taunay A, De Morais JS, Fraser DW, Feldman RA. Spread of meningococcal infection within households. Lancet. 1994;1:1275-1278.
14. De Wals P, Hertoghe L, Borlee-Grimee I, et al. Meningococcal diease in Belgium: secondary attack rate among household, day-care nursery, and preelementary school contacts. J Infect. 1981;3(suppl 1):53-61.
15. Favorova LA, Sokova IN, Cherynshova TF, et al. Results of controlled epidemiologic trial on the use of placental gamma-globulin in the foci of meningococcus infection. Zh Mikrobiol Epidemiol Immunobiol. 1975;6:15-18.
16. Olivares R, Hubert B. Clusters of meningococcal disease in France (1987-1988). Eur J Epidemiol. 1992;8:737-742.
17. Counts GW, Gregory DF, Spearman JG, et al. Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program. Rev Infect Dis. 1984;6:640-8.
18. Wang J-F, Caugant DA, Morelli G, Koumare B, Achtman M. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis. 1993;167:1320-1329.
19. Schwartz B, Moore PS, Broome CV. Global epidemiology of maningococcal disease. Clin Microbiol Rev. 1989;2:S118-S124.
20. Hoge CW, Fisher L, Connell D, et al. Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol. 1994;139:520-530.
21. Cheek JE, Baron R, Atlas H, Wilson DL, Crider RD Jr. Mumps outbreak in a highly vaccinated school population: evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med. 1995;149:774-778.
22. Alexander JP, Chapman LE, Pallansch MA, Stephenson WT, Torok TJ, Anderson LJ. Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J Infect Dis. 1993;167:1201-1205.
23. Moore PS, Hierholzer J, DeWitt W, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA. 1990;264:1271-1275.
24. Centers for Disease Control. Recommendation of the Immunization Practices Advisory Committee (ACIP): meningococcal vaccines. MMWR Morb Mortal Wkly Rep. 1985;34:255-259.
25. Gaunt PN, Lambert BE. Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother. 1988;21:489-496.
26. Schwartz B, Al-Tobaiqi A, Al-Ruwais A, et al. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet. 1988;2:1239-1242.